Evidence map›Paper›PMID 40910005›Full record

ReviewFrontiers in pharmacology2025

Multimodal integration strategies for clinical application in oncology.

Baoyi Zhang, Zhuoya Wan, Yige Luo, Xi Zhao, Josue Samayoa, Weilong Zhao, Si Wu

Abstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Baoyi ZhangAbbVie Bay Area, South San Francisco, CA, United States.
Zhuoya WanAbbVie, Inc., North Chicago, IL, United States.
Yige LuoAbbVie Bay Area, South San Francisco, CA, United States.
Xi ZhaoAbbVie Bay Area, South San Francisco, CA, United States.
Josue SamayoaAbbVie Bay Area, South San Francisco, CA, United States.
Weilong ZhaoAbbVie Bay Area, South San Francisco, CA, United States.
Si WuAbbVie Bay Area, South San Francisco, CA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In clinical practice, a variety of techniques are employed to generate diverse data types for each cancer patient. These data types, spanning clinical, genomics, imaging, and other modalities, exhibit significant differences and possess distinct data structures. Therefore, most current analyses focus on a single data modality, limiting the potential of fully utilizing all available data and providing comprehensive insights. Artificial intelligence (AI) methods, adept at handling complex data structures, offer a powerful approach to efficiently integrate multimodal data. The insights derived from such models may ultimately expedite advancements in patient diagnosis, prognosis, and treatment responses. Here, we provide an overview of current advanced multimodal integration strategies and the related clinical potential in oncology field. We start from the key processing methods for single data modalities such as multi-omics, imaging data, and clinical notes. We then include diverse AI methods, covering traditional machine learning, representation learning, and vision language model, tailored to each distinct data modality. We further elaborate on popular multimodal integration strategies and discuss the related strength and weakness. Finally, we explore potential clinical applications including early detection/diagnosis, biomarker discovery, and prediction of clinical outcome. Additionally, we discuss ongoing challenges and outline potential future directions in the field.

Indexed as

biomarkerdeep learningmultimodal integrationoncologyprognosistreatment response

Identifiers

PMID40910005
PMCPMC12405423

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.